COVID-19 |

 


September 27, 2021

Presentations

 

March 29, 2021

Presentations

  • CSR Advisory Council Update – Dr. Noni Byrnes, CSR Director
  • Simplifying Review Criteria for Clinical Trials Working Group
    Co-Chairs - Dr. Bruce Reed, CSR Deputy Director and Dr. Tonya Palermo, University of Washington, CSR Advisory Council Member
    CSR Advisory Council Members - Dr. Alfred George, Northwestern University and Dr. Yasmin Hurd, Mount Sinai School of Medicine
    Ad-hocs - Dr. Brian Boyd, University of Kansas; Dr. Matthew Carpenter, Medical University of South Carolina; Dr. Michelle Janelsins, University of Rochester; Dr. Brooks King-Casas, Virginia Tech University; Dr. Pamela Munster, University of California San Francisco
    NIH Staff - Dr. Sally Amero, NIH Review Policy Officer, Office of Extramural Research
  • ENQUIRE Recommendations: Molecular and Cellular Biology Study Sections - Dr. Ray Jacobson, Director, Division of Basic and Integrative Biology, CSR

Final Reports

 


September 21, 2020

Presentations

  • CSR Advisory Council Update – Dr. Noni Byrnes, CSR Director
  • Simplifying Review Criteria for Clinical Trials Working Group
    Co-Chairs: Dr. Bruce Reed, CSR Deputy Director and Dr. Tonya Palermo, University of Washington, CSR Advisory Council Member
    CSR Advisory Council Members - Dr. Alfred George, Northwestern University and Dr. Yasmin Hurd, Mount Sinai School of Medicine
    Ad-hocs - Dr. Brian Boyd, University of Kansas; Dr. Matthew Carpenter, Medical University of South Carolina; Dr. Brooks King-Casas, Virginia Tech University; Dr. Pamela Munster, University of California San Francisco
    NIH Staff - Dr. Sally Amero, NIH Review Policy Officer, Office of Extramural Research
  • Public Forums on Racial Disparities in NIH Funding – Dr. Bruce Reed, CSR Deputy Director

Final Reports

Public Forums on Racial Disparities in NIH Funding
CSR held three public forums in July to discuss racial disparities in NIH funding and potential bias in peer review. The report below summarizes the comments CSR received through these public forums and via email following the forums.


 

 March 30, 2020

Presentations

  • CSR Advisory Council Update – Dr. Noni Byrnes, CSR Director: Slides & Video
  • CSR Advisory Council Workgroup: Simplifying Review Criteria – Dr. Bruce Reed, CSR Deputy Director & Dr. Tonya Palermo, University of Washington, CSR Advisory Council Member: Slides & Video

Final Reports

ENQUIRE 2019
These reports detail the changes in scientific scope for study sections evaluated under the ENQUIRE process in 2019. ENQUIRE integrates data and input from multiple stakeholders – the external scientific community, extramural programs at NIH, and CSR staff to consider changes necessary to facilitate the identification of high impact science, with special consideration of emerging science. The changes in scientific scope detailed in these reports will be implemented for grant applications submitted for Oct 2020 grant deadlines and beyond.

Simplifying Review Criteria Working Group
A group was convened in 2020 to consider ways in which review criteria could be changed to reduce reviewer burden while facilitating the identification of high impact science (Review Matters, Feb 27, 2020). This report summarizes the recommendations of the working group and CSR Advisory Council and next steps.



September 23, 2019

Presentations

  • CSR Advisory Council Update – Dr. Noni Byrnes, Ph.D., CSR Director
  • ENQUIRE Group 16 – Healthcare Delivery and Patient Management – Dr. Valerie Durrant, Ph.D., CSR DABP Director
  • ENQUIRE Group 9 – Gastroinstestinal, Renal, Endocrine, Metabolism - Dr. Larry Boerboom, Ph.D., CSR DPPS Director
  • ENQUIRE Group 6 – Cardiovascular, Vascular, and Hematology – Dr. John Bowers, Ph.D., CSR DTCS Director
  • ENQUIRE Group 11 – Functional Neuroscience – Dr. Bruce Reed, Ph.D., CSR DNDA Director
  • SRO Training at CSR – Dr. Craig Giroux, Ph.D., CSR New SRO Training and Development Coordinator
  • The Cancer Moonshot – Dr. Dinah Singer, Ph.D., Deputy Director, National Cancer Institute
  • Early Career Reviewer Working Group
    Co-chairs and CSR Advisory Council Members - Dr. Mark Peifer, Ph.D., University of North Carolina, Chapel Hill and Dr. Elizabeth Villa, University of California San Diego
    Ad-hocs - Dr. Vinay Aakalu, M.D., MPH, University of Illinois at Chicago; Dr. Stephanie Cook, Ph.D., MPH, New York University; Dr. Lisa Jones, Ph.D., University of Maryland; Dr. Manuel Llano, M.D., Ph.D., University of Texas El Paso
    NIH Staff - Dr. Kristin Kramer, Ph.D., CSR; Dr. Antonello Pileggi, Ph.D., CSR
  • Review Integrity Training Working Group
    Chair (and CSR AC member) - Dr. Scott Miller, Yale University
    CSR AC members - Dr. Jinming Gao, Ph.D., UT Southwestern Medical Center; Dr. Deanna Kroetz, University of California San Francisco; Dr. Tonya Palermo, Ph.D., Seattle Children’s Research Institute; Dr. Denise Wilfley, Ph.D., Washington University St. Louis
    NIH Staff - Dr. Kathyrn Koeller, Ph.D., CSR Research & Review Integrity Officer; Dr. Miriam Mintzer, Ph.D., CSR; Dr. Raul Rojas, Ph.D., CSR

Final Reports

Early Career Reviewer Working Group
A working group was convened in 2019 to re-evaluate the Early Career Reviewer Program. The working group was comprised of two CSR Advisory Council members, two CSR scientific review officers, and four members of the scientific community who recently served as ECRs. The working group met in July to discuss possible changes to the program and their report was considered by the CSR Advisory Council on September 23, 2019. The report summarizes the recommendations of the working group and the final recommendations made by CSR Advisory Council.

 

 

 

March 25, 2019

Presentations

 


September 24, 2018

Presentations